SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-21-107634
Filing Date
2021-04-06
Accepted
2021-04-06 16:32:52
Documents
5

Document Format Files

Seq Description Document Type Size
1 DEFA14A d148315ddefa14a.htm DEFA14A 32865
2 GRAPHIC g148315g31g38.jpg GRAPHIC 20821
3 GRAPHIC g148315g31p51.jpg GRAPHIC 936
4 GRAPHIC g148315g49n44.jpg GRAPHIC 2182
5 GRAPHIC g148315g67e99.jpg GRAPHIC 60350
  Complete submission text file 0001193125-21-107634.txt   150508
Mailing Address 2100 WHARTON STREET SUITE 701 PITTSBURGH PA 15203
Business Address 2100 WHARTON STREET SUITE 701 PITTSBURGH PA 15203 (412) 586-5830
Krystal Biotech, Inc. (Filer) CIK: 0001711279 (see all company filings)

IRS No.: 821080209 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-38210 | Film No.: 21809516
SIC: 2836 Biological Products, (No Diagnostic Substances)